" class="no-js "lang="en-US"> Nicola Thompson - Medtech Alert
Sunday, October 12, 2025
Nicola Thompson

Nicola Thompson

About Nicola Thompson

Nicki has over 25 years’ experience in pharmaceutical and biotechnology R&D in a variety of senior scientific and leadership roles. She was previously VP and Global Head of External Drug Discovery at F. Hoffmann-La Roche Ltd and prior to that, Senior Director, Business Development for GSK’s Centre of Excellence for External Drug Discovery (CEEDD). Nicki’s Biotech experience includes her role as Chair of the Board for Nanna Therapeutics Ltd, founding CEO of VirionHealth and Head of Drug Discovery at Syntaxin Ltd. She holds a PhD in Cell Biology from University College London.

Related Story

Amphista Therapeutics Appoints Dr Martin Pass as CDO

December 6 2021

Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the […]

Amphista Therapeutics Appoints CBO, Beverley Carr

November 1 2021

Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the […]

Amphista Therapeutics Appoints New Chairman, Joshua T. Brumm

September 21 2021

Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the […]